Bottom line
RYHCX vs IYH: the short answer
RYHCX (Health Care Fund) and IYH (iShares U.S. Healthcare ETF) are both mutual funds.
IYH is cheaper at 0.37% vs 2.4% — a difference of $203 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +4.1% for RYHCX.
Updated Nov 19, 2026
RYHCX vs IYH side by side
| RYHCX | IYH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Guggenheim | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.4% | 0.37% |
| Annual cost per $10k | $240 | $37 |
| 10-yr cost on $10k (prospectus) | $2,782 | $468 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +12.3% | +13.1% |
| 5-yr return (annualized) | +4.1% | +7.0% |
| 10-yr return (annualized) | +6.8% | +9.4% |
| Best quarter | +18.4% | +15.3% |
| Worst quarter | −14.6% | −12.7% |
| Net assets (fund) | $19.4M | $3.6B |
| Number of holdings | 135 | 103 |
| Portfolio turnover | 244% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RYHCX | IYH | Difference |
|---|---|---|---|
| 2025 | +13.3% | +13.1% | +0.2% |
| 2024 | −0.4% | +3.1% | −3.5% |
| 2023 | +4.8% | +2.1% | +2.8% |
| 2022 | −12.5% | −4.4% | −8.1% |
| 2021 | +18.1% | +23.4% | −5.3% |
| 2020 | +17.7% | +15.5% | +2.3% |
| 2019 | +21.6% | +20.8% | +0.8% |
| 2018 | +0.5% | +5.9% | −5.4% |
| 2017 | +22.3% | +22.3% | 0.0% |
| 2016 | −10.3% | −2.8% | −7.5% |
Source: Fund prospectus bar charts
Holdings overlap
21 of RYHCX's top 25 holdings also appear in IYH's top 25.
| Holding | RYHCX | IYH |
|---|---|---|
| Eli Lilly & Company | 3.63% | 15.11% |
| Johnson & Johnson | 2.88% | 10.17% |
| Abbvie Inc | 2.52% | 7.32% |
| Unitedhealth Group Inc | 2.22% | 6.16% |
| Merck & Company Inc | 2.04% | 5.31% |
| Thermo Fisher Scientific Inc | 1.61% | 3.52% |
| Amgen Inc | 1.56% | 3.42% |
| Abbott Laboratories | 1.42% | 3.02% |
| Gilead Sciences Inc | 1.39% | 2.66% |
| Vertex Pharmaceuticals Inc | 1.34% | 2.00% |
| Intuitive Surgical Inc | 1.31% | 2.05% |
| Danaher Corp | 1.30% | 2.03% |
| Pfizer Inc | 1.25% | 2.35% |
| Bristol-myers Squibb Company | 1.22% | 2.20% |
| Stryker Corp | 1.21% | 1.86% |
Source: SEC Form N-PORT
RYHCX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between RYHCX and IYH?
Which is cheaper, RYHCX or IYH?
Should I own both RYHCX and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.